Grand Pharmaceutical Group Limited
0512Pharmaceuticals
HK$4.32−0.58%As of Oct 29vs prior close
- Market cap
- $1.9B
- P/E (TTM)
- 13.5×
- P/E (FY1)
- 8.5×
- From 52W high
- −49.15%
- EPS (LTM)
- HK$0.32
- Revenue (LTM)
- HK$12.5B
- Net margin
- 8.89%
- Dividend yield
- 3.91%
Nomior Score
34
Steady ProfileBottom 20% of the scored universe
Growth50
Quality43
Value66
Momentum1
Resilience48
Growth
+8.71%revenue a year over 3 fiscal years
YE22 HK$9.6BLTM HK$12.5B
Connections
Revenue to profitYE25
10% of revenue became net profit, down 11 pts on a year.